<font color="blue">Spotty_1</font> <font color="blue">calcification_1</font> as a marker of <font color="blue">accelerated_1</font> <font color="blue">progression_2</font> <font color="blue">of_1</font> <font color="blue">coronary_2</font> <font color="blue">atherosclerosis_2</font> <font color="blue">:_2</font> insights from serial intravascular ultrasound . 
<br>
<br> OBJECTIVES The purpose of this study was to determine <font color="blue">atheroma_1</font> <font color="blue">progression_1</font> in patients with <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> <font color="blue">._1</font> 
<br> BACKGROUND Although extensively calcified <font color="blue">atherosclerotic_1</font> <font color="blue">lesions_1</font> have been proposed to be clinically quiescent , the presence of <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> within plaque has been reported to be associated with an <font color="blue">increased_1</font> <font color="blue">incidence_2</font> <font color="blue">of_2</font> <font color="blue">ischemic_2</font> <font color="blue">cardiovascular_2</font> <font color="blue">events_2</font> <font color="blue">._2</font> The relationship between <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> <font color="blue">and_1</font> <font color="blue">disease_1</font> <font color="blue">progression_1</font> has not been investigated . 
<br> METHODS A total of 1,347 stable patients with angiographic coronary artery disease underwent <font color="blue">serial_1</font> <font color="blue">evaluation_2</font> <font color="blue">of_1</font> <font color="blue">atheroma_2</font> <font color="blue">burden_2</font> <font color="blue">with_1</font> <font color="blue">intravascular_2</font> <font color="blue">ultrasound_2</font> <font color="blue">imaging_2</font> <font color="blue">._2</font> Patients with <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> were identified based on the presence of <font color="blue">lesions_1</font> <font color="blue">(_1</font> <font color="blue">1_1</font> <font color="blue">to_1</font> <font color="blue">4_1</font> <font color="blue">mm_1</font> <font color="blue">in_1</font> <font color="blue">length_1</font> <font color="blue">)_1</font> <font color="blue">containing_1</font> <font color="blue">an_1</font> <font color="blue">arc_1</font> <font color="blue">of_1</font> <font color="blue">calcification_1</font> <font color="blue">of_1</font> <font color="blue"><_1</font> <font color="blue">90°._1</font> <font color="blue">Clinical_2</font> <font color="blue">characteristics_2</font> <font color="blue">and_2</font> <font color="blue">disease_2</font> <font color="blue">progression_2</font> were compared between patients with <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> ( n = 922 ) and those with <font color="blue">no_1</font> <font color="blue">calcification_1</font> ( n = 425 ) . 
<br> RESULTS Patients with <font color="blue">spotty_3</font> <font color="blue">calcification_3</font> <font color="blue">were_1</font> <font color="blue">older_3</font> <font color="blue">(_1</font> <font color="blue">age_1</font> <font color="blue">56_1</font> <font color="blue">years_1</font> <font color="blue">vs._1</font> <font color="blue">54_1</font> <font color="blue">years_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue">=_1</font> <font color="blue">0.001_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">more_1</font> <font color="blue">likely_1</font> <font color="blue">to_1</font> <font color="blue">be_1</font> <font color="blue">male_1</font> <font color="blue">(_1</font> <font color="blue">68%_1</font> <font color="blue">vs._1</font> <font color="blue">54%_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue">=_1</font> <font color="blue">0.01_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">have_1</font> <font color="blue">a_1</font> <font color="blue">history_2</font> <font color="blue">of_2</font> <font color="blue">diabetes_4</font> <font color="blue">mellitus_4</font> <font color="blue">(_1</font> <font color="blue">30%_1</font> <font color="blue">vs._1</font> <font color="blue">24%_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue">=_1</font> <font color="blue">0.01_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">myocardial_3</font> <font color="blue">infarction_3</font> <font color="blue">(_1</font> <font color="blue">28%_1</font> <font color="blue">vs._1</font> <font color="blue">20%_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue">=_1</font> <font color="blue">0.004_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">have_1</font> <font color="blue">lower_3</font> <font color="blue">on_4</font> <font color="blue">-_4</font> <font color="blue">treatment_4</font> <font color="blue">high_4</font> <font color="blue">-_4</font> <font color="blue">density_4</font> <font color="blue">lipoprotein_4</font> <font color="blue">cholesterol_4</font> <font color="blue">levels_4</font> ( 48 ± 16 mg / dl vs. 51 ± 17 mg / dl ; p = 0.001 ) . Patients with spotty calcification demonstrated a <font color="blue">greater_1</font> <font color="blue">percent_1</font> <font color="blue">atheroma_3</font> <font color="blue">volume_3</font> <font color="blue">(_3</font> <font color="blue">PAV_3</font> <font color="blue">)_3</font> ( 36.0 ± 7.6% vs. 29.0 ± 8.5% ; p < 0.001 ) and <font color="blue">total_2</font> <font color="blue">atheroma_2</font> <font color="blue">volume_2</font> ( 174.6 ± 71.9 mm(3 ) vs. 133.9 ± 64.9 mm(3 ) ; p < 0.001 ) . On serial evaluation , <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> was associated with <font color="blue">greater_3</font> <font color="blue">progression_4</font> <font color="blue">of_4</font> <font color="blue">PAV_4</font> ( + 0.43 ± 0.07% vs. + 0.02 ± 0.11% ; p = 0.002 ) . Although <font color="blue">intensive_1</font> <font color="blue">low_1</font> <font color="blue">-_1</font> <font color="blue">density_1</font> <font color="blue">lipoprotein_1</font> <font color="blue">cholesterol_1</font> and <font color="blue">blood_1</font> <font color="blue">pressure_1</font> <font color="blue">lowering_1</font> therapy slowed <font color="blue">disease_2</font> <font color="blue">progression_2</font> <font color="blue">,_2</font> these efficacies were attenuated in patients with <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> <font color="blue">._1</font> 
<br> CONCLUSIONS The presence of <font color="blue">spotty_1</font> <font color="blue">calcification_1</font> is associated with <font color="blue">more_2</font> <font color="blue">extensive_2</font> <font color="blue">and_2</font> <font color="blue">diffuse_2</font> <font color="blue">coronary_3</font> <font color="blue">atherosclerosis_3</font> <font color="blue">and_2</font> <font color="blue">accelerated_2</font> <font color="blue">disease_2</font> <font color="blue">progression_2</font> despite use of medical therapies .